The European cell sheet-based gene treatment market is experiencing significant expansion. This field is driven by an increasing need for innovative therapeutic solutions to address a broad range of genetic diseases. Promising clinical trials and regulatory approvals are fueling market momentum. A key factor contributing to this trend is the potent… Read More